Thrivent Financial for Lutherans’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Sell |
19,890
-3,090
| -13% | -$216K | ﹤0.01% | 1579 |
|
|
2025
Q1 | $1.49M | Sell |
22,980
-3,385
| -13% | -$219K | ﹤0.01% | 1450 |
|
|
2024
Q4 | $1.71M | Sell |
26,365
-18,090
| -41% | -$1.17M | ﹤0.01% | 1551 |
|
|
2024
Q3 | $3.46M | Sell |
44,455
-1,328,350
| -97% | -$103M | 0.01% | 1105 |
|
|
2024
Q2 | $107M | Sell |
1,372,805
-41,164
| -3% | -$3.21M | 0.22% | 113 |
|
|
2024
Q1 | $95.8M | Buy |
1,413,969
+381,837
| +37% | +$25.9M | 0.19% | 137 |
|
|
2023
Q4 | $69.5M | Buy |
1,032,132
+374,489
| +57% | +$25.2M | 0.15% | 193 |
|
|
2023
Q3 | $44.5M | Sell |
657,643
-3,144
| -0.5% | -$213K | 0.11% | 251 |
|
|
2023
Q2 | $47.3M | Sell |
660,787
-1,430,071
| -68% | -$102M | 0.11% | 243 |
|
|
2023
Q1 | $145M | Buy |
2,090,858
+837,645
| +67% | +$58.1M | 0.35% | 51 |
|
|
2022
Q4 | $85M | Sell |
1,253,213
-29,824
| -2% | -$2.02M | 0.22% | 120 |
|
|
2022
Q3 | $70.4M | Buy |
1,283,037
+2,229
| +0.2% | +$122K | 0.19% | 141 |
|
|
2022
Q2 | $84.6M | Sell |
1,280,808
-42,080
| -3% | -$2.78M | 0.23% | 105 |
|
|
2022
Q1 | $87.8M | Buy |
+1,322,888
| New | +$87.8M | 0.17% | 154 |
|
|
2017
Q4 | – | Sell |
-548
| Closed | -$18K | – | 2034 |
|
|
2017
Q3 | $18K | Buy |
+548
| New | +$18K | ﹤0.01% | 2090 |
|